|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 701 to 800 out of 1013 for Braf

0.024s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
Publication
First Author: Murphy BM
Year: 2022
Journal: Nat Commun
Title: Enhanced BRAF engagement by NRAS mutants capable of promoting melanoma initiation.
Volume: 13
Issue: 1
Pages: 3153
Publication
First Author: Han S
Year: 2018
Journal: Nat Commun
Title: ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma.
Volume: 9
Issue: 1
Pages: 28
Publication
First Author: Saei A
Year: 2018
Journal: J Exp Med
Title: Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies.
Volume: 215
Issue: 7
Pages: 1913-1928
HT Experiment  
Experiment Type: RNA-Seq
Study Type: WT vs. Mutant
Source: GEO
Publication
First Author: Jeong JH
Year: 2008
Journal: PLoS One
Title: BRAF activation initiates but does not maintain invasive prostate adenocarcinoma.
Volume: 3
Issue: 12
Pages: e3949
Allele
Name: Braf transforming gene; endonuclease-mediated mutation 2, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Null/knockout
Publication
First Author: Wan L
Year: 2017
Journal: Cancer Discov
Title: The APC/C E3 Ligase Complex Activator FZR1 Restricts BRAF Oncogenic Function.
Volume: 7
Issue: 4
Pages: 424-441
Publication
First Author: Koya RC
Year: 2012
Journal: Cancer Res
Title: BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy.
Volume: 72
Issue: 16
Pages: 3928-37
Publication
First Author: Dankner M
Year: 2018
Journal: Oncogene
Title: Classifying BRAF alterations in cancer: new rational therapeutic strategies for actionable mutations.
Volume: 37
Issue: 24
Pages: 3183-3199
Publication
First Author: Vacher J
Year: 1999
Journal: Mamm Genome
Title: Genetic localization and transmission of the mouse osteopetrotic grey-lethal mutation.
Volume: 10
Issue: 3
Pages: 239-43
Publication
First Author: Wadewitz AG
Year: 1993
Journal: Oncogene
Title: Developmental and cell lineage specificity of raf family gene expression in mouse testis.
Volume: 8
Issue: 4
Pages: 1055-62
Publication
First Author: Karreth FA
Year: 2015
Journal: Cell
Title: The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo.
Volume: 161
Issue: 2
Pages: 319-32
Publication
First Author: Gandolfi G
Year: 2015
Journal: Int J Cancer
Title: Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma.
Volume: 137
Issue: 5
Pages: 1001-11
Publication
First Author: Lim CS
Year: 2017
Journal: Genes Dev
Title: BRaf signaling principles unveiled by large-scale human mutation analysis with a rapid lentivirus-based gene replacement method.
Volume: 31
Issue: 6
Pages: 537-552
Publication
First Author: Yun J
Year: 2015
Journal: Science
Title: Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH.
Volume: 350
Issue: 6266
Pages: 1391-6
Publication
First Author: Lavoie H
Year: 2018
Journal: Nature
Title: MEK drives BRAF activation through allosteric control of KSR proteins.
Volume: 554
Issue: 7693
Pages: 549-553
Publication
First Author: Riemer P
Year: 2015
Journal: Oncogene
Title: Transgenic expression of oncogenic BRAF induces loss of stem cells in the mouse intestine, which is antagonized by β-catenin activity.
Volume: 34
Issue: 24
Pages: 3164-75
Publication
First Author: Ramsdale R
Year: 2015
Journal: Sci Signal
Title: The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma.
Volume: 8
Issue: 390
Pages: ra82
Publication
First Author: Ferrari de Andrade L
Year: 2014
Journal: Cancer Res
Title: Natural killer cells are essential for the ability of BRAF inhibitors to control BRAFV600E-mutant metastatic melanoma.
Volume: 74
Issue: 24
Pages: 7298-308
Publication
First Author: Su F
Year: 2012
Journal: N Engl J Med
Title: RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors.
Volume: 366
Issue: 3
Pages: 207-15
Publication
First Author: Younes ST
Year: 2020
Journal: PLoS One
Title: In silico analysis identifies a putative cell-of-origin for BRAF fusion-positive cerebellar pilocytic astrocytoma.
Volume: 15
Issue: 11
Pages: e0242521
Publication  
First Author: Dorfer S
Year: 2024
Journal: Cancers (Basel)
Title: BRAF Inhibition and UVB Light Synergistically Promote Mus musculus Papillomavirus 1-Induced Skin Tumorigenesis.
Volume: 16
Issue: 18
Strain
Attribute String: coisogenic, mutant strain, targeted mutation
Publication
First Author: Faber AC
Year: 2014
Journal: Cancer Discov
Title: mTOR inhibition specifically sensitizes colorectal cancers with KRAS or BRAF mutations to BCL-2/BCL-XL inhibition by suppressing MCL-1.
Volume: 4
Issue: 1
Pages: 42-52
Publication
First Author: Wojnowski L
Year: 1998
Journal: Mamm Genome
Title: Reduced activity of BRAF protein kinase in hop and hop(hpy) mouse mutants.
Volume: 9
Issue: 11
Pages: 905-6
Publication
First Author: Ji H
Year: 2007
Journal: Cancer Res
Title: Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse models.
Volume: 67
Issue: 10
Pages: 4933-9
Publication
First Author: Duggan MC
Year: 2017
Journal: Proc Natl Acad Sci U S A
Title: Identification of NRAS isoform 2 overexpression as a mechanism facilitating BRAF inhibitor resistance in malignant melanoma.
Volume: 114
Issue: 36
Pages: 9629-9634
Publication
First Author: Moriya A
Year: 2025
Journal: Hum Mol Genet
Title: Q241R mutation of Braf causes neurological abnormalities in a mouse model of cardio-facio-cutaneous syndrome, independent of developmental malformations.
Volume: 34
Issue: 5
Pages: 418-434
Allele
Name: Braf transforming gene; endonuclease-mediated mutation 1, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Conditional ready, No functional change
Publication
First Author: Zhang ZX
Year: 2015
Journal: Biochem Biophys Res Commun
Title: BRAF activated non-coding RNA (BANCR) promoting gastric cancer cells proliferation via regulation of NF-κB1.
Volume: 465
Issue: 2
Pages: 225-31
Publication  
First Author: Tripathi S
Year: 2024
Journal: J Clin Invest
Title: Pediatric glioma immune profiling identifies TIM3 as a therapeutic target in BRAF fusion pilocytic astrocytoma.
Volume: 134
Issue: 19
Strain
Attribute String: coisogenic, endonuclease-mediated mutation, mutant strain
Publication
First Author: Jones DT
Year: 2008
Journal: Cancer Res
Title: Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas.
Volume: 68
Issue: 21
Pages: 8673-7
Interaction Experiment
Description: BAG3 down-modulation reduces anaplastic thyroid tumor growth by enhancing proteasome-mediated degradation of BRAF protein.
Publication
First Author: Buffet C
Year: 2017
Journal: PLoS One
Title: DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers.
Volume: 12
Issue: 9
Pages: e0184861
Allele
Name: Braf transforming gene; targeted mutation 1, Martin McMahon
Allele Type: Targeted
Attribute String: Conditional ready, No functional change
Allele
Name: Braf transforming gene; targeted mutation 1.1, Tilman Brummer
Allele Type: Targeted
Attribute String: Conditional ready
Allele  
Name: Braf transforming gene; targeted mutation 1.2, Tilman Brummer
Allele Type: Targeted
Allele
Name: Braf transforming gene; targeted mutation 2, Martin McMahon
Allele Type: Targeted
Attribute String: Conditional ready, Humanized sequence, No functional change
Allele  
Name: Braf transforming gene; wild type
Allele Type: Not Specified
Allele
Name: Braf transforming gene; targeted mutation 1, Catrin Pritchard
Allele Type: Targeted
Attribute String: Conditional ready, Humanized sequence, No functional change
Publication
First Author: Jones DT
Year: 2009
Journal: Oncogene
Title: Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma.
Volume: 28
Issue: 20
Pages: 2119-23
DO Term
DO Term
Strain
Attribute String: coisogenic, endonuclease-mediated mutation, mutant strain
Strain
Attribute String: mutant stock, targeted mutation
Allele  
Name: Braf transforming gene; gene trap XE282, BayGenomics
Allele Type: Gene trapped
Allele  
Name: Braf transforming gene; gene trap XE617, BayGenomics
Allele Type: Gene trapped
Allele  
Name: Braf transforming gene; gene trap XN124, BayGenomics
Allele Type: Gene trapped
Allele  
Name: Braf transforming gene; gene trap RRO367, BayGenomics
Allele Type: Gene trapped
Allele  
Name: Braf transforming gene; gene trap RRS254, BayGenomics
Allele Type: Gene trapped
Strain
Attribute String: mutant stock, targeted mutation
Strain
Attribute String: mutant strain, congenic, targeted mutation
DO Term
Publication
First Author: Lee JH
Year: 2006
Journal: Pathology
Title: BRAF mutation and AKAP9 expression in sporadic papillary thyroid carcinomas.
Volume: 38
Issue: 3
Pages: 201-4
Genotype
Symbol: Braf/Braf
Background: involves: 129P2/OlaHsd * C57BL/6
Zygosity: cn
Has Mutant Allele: true
Allele
Name: Braf transforming gene; targeted mutation 1, Andreas Zimmer
Allele Type: Targeted
Attribute String: Null/knockout
Allele    
Name: Braf transforming gene, related sequence 1; wild type
Allele
Name: Braf transforming gene; targeted mutation 1, Alcino J Silva
Allele Type: Targeted
Attribute String: Conditional ready, No functional change
Allele
Name: Braf transforming gene; targeted mutation 1.1, Alcino Silva
Allele Type: Targeted
Attribute String: Null/knockout
Allele  
Name: Braf transforming gene; targeted mutation 1, Ulf R Rapp
Allele Type: Targeted
Allele
Name: Braf transforming gene; targeted mutation 1, William D Snider
Allele Type: Targeted
Attribute String: Conditional ready, No functional change
Allele
Name: Braf transforming gene; targeted mutation 1.1, William D Snider
Allele Type: Targeted
Attribute String: Null/knockout
Allele  
Name: Braf transforming gene; gene trap AY0605, Wellcome Trust Sanger Institute
Allele Type: Gene trapped
Allele  
Name: Braf transforming gene; gene trap AN0584, Wellcome Trust Sanger Institute
Allele Type: Gene trapped
Allele  
Name: Braf transforming gene; gene trap BA0436, Wellcome Trust Sanger Institute
Allele Type: Gene trapped
Allele  
Name: Braf transforming gene; gene trap CH0627, Wellcome Trust Sanger Institute
Allele Type: Gene trapped
Allele  
Name: Braf transforming gene; gene trap F045D02, German Gene Trap Consortium
Allele Type: Gene trapped
Allele  
Name: Braf transforming gene; gene trap OST40239, Lexicon Genetics
Allele Type: Gene trapped
Allele  
Name: Braf transforming gene; gene trap OST60560, Lexicon Genetics
Allele Type: Gene trapped
Allele  
Name: Braf transforming gene; gene trap OST309428, Lexicon Genetics
Allele Type: Gene trapped
Allele  
Name: Braf transforming gene; gene trap OST364120, Lexicon Genetics
Allele Type: Gene trapped
Allele  
Name: Braf transforming gene; gene trap OST379833, Lexicon Genetics
Allele Type: Gene trapped
Allele  
Name: Braf transforming gene; gene trap OST436107, Lexicon Genetics
Allele Type: Gene trapped
Allele  
Name: Braf transforming gene; gene trap AA0135, Wellcome Trust Sanger Institute
Allele Type: Gene trapped
Allele  
Name: Braf transforming gene; gene trap AT0126, Wellcome Trust Sanger Institute
Allele Type: Gene trapped
Allele  
Name: Braf transforming gene; gene trap EUCE00111f02, Helmholtz Zentrum Muenchen GmbH
Allele Type: Gene trapped
Allele  
Name: Braf transforming gene; gene trap EUCE00115e08, Helmholtz Zentrum Muenchen GmbH
Allele Type: Gene trapped
Allele  
Name: Braf transforming gene; gene trap EUCE0154c11, Helmholtz Zentrum Muenchen GmbH
Allele Type: Gene trapped
Allele
Name: Braf transforming gene; targeted mutation 1, Richard Marais
Allele Type: Targeted
Attribute String: Conditional ready, No functional change
Allele
Name: Braf transforming gene; targeted mutation 1a, Wellcome Trust Sanger Institute
Allele Type: Targeted
Attribute String: Conditional ready, Null/knockout, Reporter
Allele
Name: Braf transforming gene; targeted mutation 1e, Wellcome Trust Sanger Institute
Allele Type: Targeted
Attribute String: Null/knockout, Reporter
Allele
Name: Braf transforming gene; targeted mutation 1.1, Alain Eychene
Allele Type: Targeted
Attribute String: Modified isoform(s)
Allele
Name: Braf transforming gene; targeted mutation 2.1, Alain Eychene
Allele Type: Targeted
Attribute String: Modified isoform(s)
Allele
Name: Braf transforming gene; targeted mutation 1, Mariano Barbacid
Allele Type: Targeted
Attribute String: Conditional ready, Humanized sequence, Hypomorph
Allele
Name: Braf transforming gene; targeted mutation 1, David A Tuveson
Allele Type: Targeted
Attribute String: Conditional ready, No functional change
Allele
Name: Braf transforming gene; targeted mutation 2, Catrin Pritchard
Allele Type: Targeted
Attribute String: Conditional ready, No functional change
Allele
Name: Braf transforming gene; targeted mutation 2, Urr R Rapp
Allele Type: Targeted
Attribute String: Conditional ready, No functional change
Allele
Name: Braf transforming gene; targeted mutation 2.1, Urr R Rapp
Allele Type: Targeted
Attribute String: Conditional ready, No functional change
Allele
Name: Braf transforming gene; targeted mutation 2.2, Urr R Rapp
Allele Type: Targeted
Attribute String: Null/knockout
Allele
Name: Braf transforming gene; targeted mutation 1.1, Allan Bradley
Allele Type: Targeted
Attribute String: Humanized sequence
Allele
Name: Braf transforming gene; targeted mutation 1, Yoko Aoki
Allele Type: Targeted
Attribute String: Conditional ready
Allele
Name: Braf transforming gene; endonuclease-mediated mutation 1, GemPharmatech Co., Ltd
Allele Type: Endonuclease-mediated
Attribute String: Conditional ready, No functional change
Allele
Name: Braf transforming gene; endonuclease-mediated mutation 6, GemPharmatech Co., Ltd
Allele Type: Endonuclease-mediated
Attribute String: Null/knockout
Allele  
Name: Braf transforming gene; targeted mutation 1.1, Yoko Aoki
Allele Type: Targeted
Allele
Name: Braf transforming gene; endonuclease-mediated mutation 1, Cyagen Biosciences
Allele Type: Endonuclease-mediated
Attribute String: Null/knockout
Allele
Name: Braf transforming gene; endonuclease-mediated mutation 2, Cyagen Biosciences
Allele Type: Endonuclease-mediated
Attribute String: Conditional ready, No functional change
Genotype
Symbol: Braf/Braf<+>
Background: involves: 129P2/OlaHsd
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Braf/Braf<+>
Background: involves: 129P2/OlaHsd
Zygosity: ht
Has Mutant Allele: true
Genotype
Symbol: Braf/Braf<+>
Background: involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6
Zygosity: cn
Has Mutant Allele: true